Global Implementation and Return of Pharmacogenomic Results: Challenges and Innovations

Thursday, September 11, 2025, 2:00 PM - 5:30 PM

1. Describe global approaches to pharmacogenomic implementation, including the challenges and opportunities in diverse healthcare systems.
2. Discuss strategies for managing preemptive pharmacogenomic results that emerge through reactive testing workflows.
3. Summarize implications of preemptive pharmacogenomic results on clinical care and documentation.
4. Evaluate best practices for returning pharmacogenomic results from research biobanks.
5. Evaluate best practices for returning pharmacogenomic results to patients in a responsible, actionable, and patient-cented manner.

St. Jude Children's Research Hospital is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

St. Jude Children’s Research Hospital designates this for a maximum of 3.00 AMA PRA Category 1 Credits^TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ACPE - Accreditation Council for Pharmacy Education (3.00 hours), Non-Physician Attendance (3.00 hours)

Mitigation of Relevant Financial Relationships

St Jude Children's Research Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers, or others, are required to disclose all financial relationships with ineligible entities (ie, companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Thursday, September 11, 2025